1887

Journal of Medical Microbiology logo

Volume 67, Issue 2

β LACTA testing may not improve treatment decisions made with MALDI-TOF MS-informed antimicrobial stewardship advice for patients with Gram-negative bacteraemia: a prospective comparative study Free

Abstract

The aim of this study was to assess if use of the β LACTA test (BLT) for extended-spectrum beta-lactamase (ESBL) detection and/or early bacterial identification by mass spectrometry (MALDI-TOF MS) improves therapeutic decision-making when combined with advice from the antimicrobial stewardship team (AMST) for the management of Gram-negative bacillary (GNB) bacteraemia.

Prospective observational theoretical study that included patients with GNB bacteraemia during a 6-month period. We compared, against the antimicrobial choice of the local AMST as informed of the Gram-stain result, a hypothetical choice, i.e. one AMST would have made had it been informed of the MALDI-TOF MS results only (option H) with the actual choice AMST made after being informed of the combined MALDI-TOF MS and BLT results (option A).

A total of 131 episodes of GNB bacteraemia were included. Options H and A led to virtually the same rate of efficient antimicrobial therapy (in 120/131 and 123/131 episodes, respectively, =0.63). Compared to the gold standard, options H and A did not lead to a significant reduction of carbapenem prescription (9/131, 6/131 and 12/131, =0.57 and =0.65, respectively).

Under our test conditions, BLT, when used in conjunction with MALDI-TOF MS and AMST advice, did not allow a significant optimization of the antimicrobial prescription made on the basis AMST advice only. However, the impact of BLT should be evaluated in a population with high prevalence of ESBL-producing and/or when treatment choices are not made by infectious disease specialists.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antimicrobial stewardship , ESBL-E , Gram-negative bacteraemia , MALDI-TOF MS and β LACTA test
© 2018 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000665
2018-02-01
2024-12-06
Loading full text...

Full text loading...

/deliver/fulltext/jmm/67/2/183.html?itemId=/content/journal/jmm/10.1099/jmm.0.000665&mimeType=html&fmt=ahah

References

  1. Thiébaut AC, Arlet G, Andremont A, Papy E, Sollet JP et al. Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units. J Antimicrob Chemother 2012; 67:1525–1536 [View Article][PubMed]
     [Google Scholar]
  2. European Union, European Union European Centre for Disease Prevention and Control Antimicrobial resistance surveillance in Europe 2012 Luxembourg: Publications Office of the European Union; 2013
     [Google Scholar]
  3. Kumar A, Ellis P, Arabi Y, Roberts D, Light B et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 2009; 136:1237–1248 [View Article][PubMed]
     [Google Scholar]
  4. Opota O, Jaton K, Greub G. Microbial diagnosis of bloodstream infection: towards molecular diagnosis directly from blood. Clin Microbiol Infect 2015; 21:323–331 [View Article][PubMed]
     [Google Scholar]
  5. Idelevich EA, Grunewald CM, Wüllenweber J, Becker K. Rapid identification and susceptibility testing of Candida spp. from positive blood cultures by combination of direct MALDI-TOF mass spectrometry and direct inoculation of Vitek 2. PLoS One 2014; 9:e114834 [View Article][PubMed]
     [Google Scholar]
  6. Verroken A, Defourny L, Lechgar L, Magnette A, Delmée M et al. Reducing time to identification of positive blood cultures with MALDI-TOF MS analysis after a 5-h subculture. Eur J Clin Microbiol Infect Dis 2015; 34:405–413 [View Article][PubMed]
     [Google Scholar]
  7. Dortet L, Poirel L, Nordmann P. Rapid detection of ESBL-producing Enterobacteriaceae in blood cultures. Emerg Infect Dis 2015; 21:504–507 [View Article][PubMed]
     [Google Scholar]
  8. Renvoisé A, Decré D, Amarsy-Guerle R, Huang TD, Jost C et al. Evaluation of the βLacta test, a rapid test detecting resistance to third-generation cephalosporins in clinical strains of Enterobacteriaceae. J Clin Microbiol 2013; 51:4012–4017 [View Article][PubMed]
     [Google Scholar]
  9. Compain F, Bensekhri H, Rostane H, Mainardi JL, Lavollay M. β LACTA test for rapid detection of Enterobacteriaceae resistant to third-generation cephalosporins from positive blood cultures using briefly incubated solid medium cultures. J Med Microbiol 2015; 64:1256–1259 [View Article][PubMed]
     [Google Scholar]
  10. Clerc O, Prod'hom G, Vogne C, Bizzini A, Calandra T et al. Impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry on the clinical management of patients with Gram-negative bacteremia: a prospective observational study. Clin Infect Dis 2013; 56:1101–1107 [View Article][PubMed]
     [Google Scholar]
  11. Huang AM, Newton D, Kunapuli A, Gandhi TN, Washer LL et al. Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia. Clin Infect Dis 2013; 57:1237–1245 [View Article][PubMed]
     [Google Scholar]
  12. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250–1256 [View Article][PubMed]
     [Google Scholar]
  13. Weiss E, Zahar JR, Lesprit P, Ruppe E, Leone M et al. Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams. Clin Microbiol Infect 2015; 21:649.e1–649.e10 [View Article][PubMed]
     [Google Scholar]
  14. Munson EL, Diekema DJ, Beekmann SE, Chapin KC, Doern GV. Detection and treatment of bloodstream infection: laboratory reporting and antimicrobial management. J Clin Microbiol 2003; 41:495–497 [View Article][PubMed]
     [Google Scholar]
  15. Barenfanger J, Drake C, Kacich G. Clinical and financial benefits of rapid bacterial identification and antimicrobial susceptibility testing. J Clin Microbiol 1999; 37:1415–1418[PubMed]
     [Google Scholar]
  16. Bruins M, Oord H, Bloembergen P, Wolfhagen M, Casparie A et al. Lack of effect of shorter turnaround time of microbiological procedures on clinical outcomes: a randomised controlled trial among hospitalised patients in the Netherlands. Eur J Clin Microbiol Infect Dis 2005; 24:305–313 [View Article][PubMed]
     [Google Scholar]
  17. Kerremans JJ, Verboom P, Stijnen T, Hakkaart-van Roijen L, Goessens W et al. Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use. J Antimicrob Chemother 2008; 61:428–435 [View Article][PubMed]
     [Google Scholar]
  18. Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med 2013; 137:1247–1254 [View Article][PubMed]
     [Google Scholar]
  19. Perez KK, Olsen RJ, Musick WL, Cernoch PL, Davis JR et al. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia. J Infect 2014; 69:216–225 [View Article][PubMed]
     [Google Scholar]
  20. Laurent T, Huang TD, Bogaerts P, Glupczynski Y. Evaluation of the βLACTA test, a novel commercial chromogenic test for rapid detection of ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates. J Clin Microbiol 2013; 51:1951–1954 [View Article][PubMed]
     [Google Scholar]
  21. Gallah S, Decré D, Genel N, Arlet G. The β-Lacta test for direct detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae in urine. J Clin Microbiol 2014; 52:3792–3794 [View Article][PubMed]
     [Google Scholar]
  22. Defourny L. Evaluation of the βLACTA test for direct detection of resistance to third generation cephalosporin in Enterobacteriaceae and Pseudomonas aeruginosa from positive blood culture bottles. In Interscience Conference on Antimicrobial Agents and Chemotherapy 2014
     [Google Scholar]
  23. Razazi K, Derde LP, Verachten M, Legrand P, Lesprit P et al. Clinical impact and risk factors for colonization with extended- spectrum β-lactamase-producing bacteria in the intensive care unit. Intensive Care Med 2012; 38:1769–1778 [View Article][PubMed]
     [Google Scholar]
  24. Platteel TN, Leverstein-van Hall MA, Cohen Stuart JW, Thijsen SF, Mascini EM et al. Predicting carriage with extended-spectrum beta-lactamase-producing bacteria at hospital admission: a cross-sectional study. Clin Microbiol Infect 2015; 21:141–146 [View Article][PubMed]
     [Google Scholar]
  25. Goodman KE, Lessler J, Cosgrove SE, Harris AD, Lautenbach E et al. A clinical decision tree to predict whether a bacteremic patient is infected with an extended-spectrum β-lactamase-producing organism. Clin Infect Dis 2016; 63:896–903 [View Article][PubMed]
     [Google Scholar]
  26. Prod'hom G, Bizzini A, Durussel C, Bille J, Greub G. Matrix-assisted laser desorption ionization-time of flight mass spectrometry for direct bacterial identification from positive blood culture pellets. J Clin Microbiol 2010; 48:1481–1483 [View Article][PubMed]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.000665
Loading
β LACTA testing may not improve treatment decisions made with MALDI-TOF MS-informed antimicrobial stewardship advice for patients with Gram-negative bacteraemia: a prospective comparative study
J. Med. Microbiol. 67, 183 (2018); https://doi.org/10.1099/jmm.0.000665
/content/journal/jmm/10.1099/jmm.0.000665
/content/journal/jmm/10.1099/jmm.0.000665
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error